Literature DB >> 16409290

Location, movement and survival: the role of chemokines in haematopoiesis and malignancy.

Arian D J Laurence1.   

Abstract

Chemokines are a family of over 40 small (8 kDa) related proteins with the function of moving cells along a chemotactic gradient, either to organise cells within an organ or to facilitate the movement of leucocytes around the body. Mouse models have implicated the importance of the chemokine CXCL12 in haematopoiesis and this has lead to the use of the inhibitor AMD3100 for autologous transplantation. This review will briefly discuss the biology of chemokines and their role in haematopoiesis and haematological malignancy together with the possible benefits and hazards of therapeutic modification of the chemokine system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16409290     DOI: 10.1111/j.1365-2141.2005.05841.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

1.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.

Authors:  Xiqiang Liu; Antonia Kolokythas; Jianguang Wang; Hongzhang Huang; Xiaofeng Zhou
Journal:  Curr Cancer Ther Rev       Date:  2010-11-01

2.  Macrophage chemotactic protein-1 mRNA levels in non-Hodgkin lymphoma.

Authors:  Toni Valković; Antica Duletić-Načinović; Sanja Stifter; Milena Hasan; Ita Hadžisejdić; David Zombori; Blaženka Grahovac; Nives Jonjić
Journal:  Clin Exp Med       Date:  2010-03-16       Impact factor: 3.984

3.  C-C chemokine receptor 1 expression in human hematolymphoid neoplasia.

Authors:  Matthew W Anderson; Shuchun Zhao; Weiyun Z Ai; Robert Tibshirani; Ronald Levy; Izidore S Lossos; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2010-03       Impact factor: 2.493

4.  If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma.

Authors:  Patrizia Mancuso; Angelica Calleri; Pierluigi Antoniotti; Jessica Quarna; Giancarlo Pruneri; Francesco Bertolini
Journal:  BMC Cancer       Date:  2010-11-24       Impact factor: 4.430

5.  CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.

Authors:  Takumi Kumai; Toshihiro Nagato; Hiroya Kobayashi; Yuki Komabayashi; Seigo Ueda; Kan Kishibe; Takayuki Ohkuri; Miki Takahara; Esteban Celis; Yasuaki Harabuchi
Journal:  Cancer Immunol Immunother       Date:  2015-03-10       Impact factor: 6.968

6.  An in vitro method to study the effects of hematopoietic regulators during immune and blood cell development.

Authors:  Nitixa Patel; Marianne Castillo; Pranela Rameshwar
Journal:  Biol Proced Online       Date:  2007-12-14       Impact factor: 3.244

7.  CXCR4 antagonists in hematologic malignancies: more than just mobilizers?

Authors:  Deog-Yeon Jo
Journal:  Korean J Hematol       Date:  2011-12-27

Review 8.  Molecular Pathogenesis of MALT Lymphoma.

Authors:  Katharina Troppan; Kerstin Wenzl; Peter Neumeister; Alexander Deutsch
Journal:  Gastroenterol Res Pract       Date:  2015-04-01       Impact factor: 2.260

9.  Expression patterns of chemokine receptors on circulating T cells from myelodysplastic syndrome patients.

Authors:  Kristoffer Evebø Sand; Kristin Paulsen Rye; Bård Mannsåker; Oystein Bruserud; Astrid Olsnes Kittang
Journal:  Oncoimmunology       Date:  2013-02-01       Impact factor: 8.110

10.  Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.

Authors:  J Panse; K Friedrichs; A Marx; Y Hildebrandt; T Luetkens; K Barrels; C Horn; T Stahl; Y Cao; K Milde-Langosch; A Niendorf; N Kröger; S Wenzel; R Leuwer; C Bokemeyer; S Hegewisch-Becker; D Atanackovic
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.